Cargando…

Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases

Neurodegenerative diseases (NDs) represent a heterogeneous group of aging-related disorders featured by progressive impairment of motor and/or cognitive functions, often accompanied by psychiatric disorders. NDs are denoted as ‘protein misfolding’ diseases or proteinopathies, and are classified acco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riccardi, Claudia, Napolitano, Filomena, Montesarchio, Daniela, Sampaolo, Simone, Melone, Mariarosa Anna Beatrice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623286/ https://www.ncbi.nlm.nih.gov/pubmed/34834311 http://dx.doi.org/10.3390/pharmaceutics13111897

Ejemplares similares

Understanding the Biological Activities of Vitamin D in Type 1 Neurofibromatosis: New Insights into Disease Pathogenesis and Therapeutic Design
por: Riccardi, Claudia, et al.
Publicado: (2020)

The Autophagy Signaling Pathway: A Potential Multifunctional Therapeutic Target of Curcumin in Neurological and Neuromuscular Diseases
por: Perrone, Lorena, et al.
Publicado: (2019)

Bioactive Phenolic Compounds in the Modulation of Central and Peripheral Nervous System Cancers: Facts and Misdeeds
por: Perrone, Lorena, et al.
Publicado: (2020)

Fighting the Huntington’s Disease with a G-Quadruplex-Forming Aptamer Specifically Binding to Mutant Huntingtin Protein: Biophysical Characterization, In Vitro and In Vivo Studies
por: Riccardi, Claudia, et al.
Publicado: (2022)

Truncated Analogues of a G-Quadruplex-Forming Aptamer Targeting Mutant Huntingtin: Shorter Is Better!
por: Riccardi, Claudia, et al.
Publicado: (2022)

Late adult-onset adrenomyeloneuropathy evolving with atypical severe frontal lobe syndrome: Importance of neuroimaging
por: Dato, Clemente, et al.
Publicado: (2018)

Genotype-Phenotype Correlations in Neurofibromatosis Type 1: Identification of Novel and Recurrent NF1 Gene Variants and Correlations with Neurocognitive Phenotype
por: Napolitano, Filomena, et al.
Publicado: (2022)

Rasagiline for sleep disorders in patients with Parkinson’s disease: a prospective observational study
por: Schettino, Carla, et al.
Publicado: (2016)

Rare Variants in Autophagy and Non-Autophagy Genes in Late-Onset Pompe Disease: Suggestions of Their Disease-Modifying Role in Two Italian Families
por: Napolitano, Filomena, et al.
Publicado: (2021)

Dimeric and Multimeric DNA Aptamers for Highly Effective Protein Recognition
por: Riccardi, Claudia, et al.
Publicado: (2020)

Disentangling the Structure–Activity Relationships of Naphthalene Diimides as Anticancer G-Quadruplex-Targeting Drugs
por: Platella, Chiara, et al.
Publicado: (2021)

Affinity Chromatography‐Based Assays for the Screening of Potential Ligands Selective for G‐Quadruplex Structures
por: Platella, Chiara, et al.
Publicado: (2022)

Synergistic Interplay between Curcumin and Polyphenol-Rich Foods in the Mediterranean Diet: Therapeutic Prospects for Neurofibromatosis 1 Patients
por: Esposito, Teresa, et al.
Publicado: (2017)

Insights into the Small Molecule Targeting of Biologically Relevant G-Quadruplexes: An Overview of NMR and Crystal Structures
por: Criscuolo, Andrea, et al.
Publicado: (2022)

Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington’s Disease
por: Giampà, Carmela, et al.
Publicado: (2013)

Correction: Systemic Delivery of Recombinant Brain Derived Neurotrophic Factor (BDNF) in the R6/2 Mouse Model of Huntington's Disease
por: Giampà, Carmela, et al.
Publicado: (2016)

The Delivery Challenge in Neurodegenerative Disorders: The Nanoparticles Role in Alzheimer’s Disease Therapeutics and Diagnostics
por: de la Torre, Cristina, et al.
Publicado: (2018)

Nanoparticle-Based Drug Delivery Systems: An Inspiring Therapeutic Strategy for Neurodegenerative Diseases
por: Duan, Linyan, et al.
Publicado: (2023)

G-Quadruplex Forming Oligonucleotides as Anti-HIV Agents
por: Musumeci, Domenica, et al.
Publicado: (2015)

Intranasal Delivery of Targeted Nanoparticles Loaded With miR-132 to Brain for the Treatment of Neurodegenerative Diseases
por: Su, Yu, et al.
Publicado: (2020)

Design, Synthesis, and Characterization of an Amphiphilic Lipoic Acid-Based Ru(III) Complex as a Versatile Tool for the Functionalization of Different Nanosystems
por: Riccardi, Claudia, et al.
Publicado: (2023)

Trimethyl Chitosan Hydrogel Nanoparticles for Progesterone Delivery in Neurodegenerative Disorders †
por: Cardia, Maria Cristina, et al.
Publicado: (2019)

PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases
por: Cunha, Anthony, et al.
Publicado: (2021)

The Gut Microbiome–Brain Crosstalk in Neurodegenerative Diseases
por: Ghezzi, Laura, et al.
Publicado: (2022)

The Discovery of Highly Potent THP Derivatives as OCTN2 Inhibitors: From Structure-Based Virtual Screening to In Vivo Biological Activity
por: Di Cristo, Francesca, et al.
Publicado: (2020)

The carnitine system and cancer metabolic plasticity
por: Melone, Mariarosa Anna Beatrice, et al.
Publicado: (2018)

A terminal functionalization strategy reveals unusual binding abilities of anti-thrombin anticoagulant aptamers
por: Troisi, Romualdo, et al.
Publicado: (2022)

Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics
por: Musumeci, Domenica, et al.
Publicado: (2017)

Targeting Mitochondrial Dysfunction in Neurodegenerative Diseases: Expanding the Therapeutic Approaches by Plant-Derived Natural Products
por: Zhang, Xiaoyue, et al.
Publicado: (2023)

Delivery of stem cells to the brain: potential for treatment of neurodegenerative disease
por: Burgess, Alison, et al.
Publicado: (2015)

G-quadruplex-based aptamers against protein targets in therapy and diagnostics()
por: Platella, Chiara, et al.
Publicado: (2017)

Biomarker-guided classification scheme of neurodegenerative diseases
por: Baldacci, Filippo, et al.
Publicado: (2016)

Biocompatible Polymer Nanoparticles for Drug Delivery Applications in Cancer and Neurodegenerative Disorder Therapies
por: Calzoni, Eleonora, et al.
Publicado: (2019)

Digenic mutational inheritance of the integrin alpha 7 and the myosin heavy chain 7B genes causes congenital myopathy with left ventricular non-compact cardiomyopathy
por: Esposito, Teresa, et al.
Publicado: (2013)

Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem
por: Ferraro, Maria Grazia, et al.
Publicado: (2023)

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease
por: Hanson, Leah R, et al.
Publicado: (2008)

Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders
por: Boyuklieva, Radka, et al.
Publicado: (2022)

Anticancer Ruthenium(III) Complexes and Ru(III)-Containing Nanoformulations: An Update on the Mechanism of Action and Biological Activity
por: Riccardi, Claudia, et al.
Publicado: (2019)

Tuning the Polymorphism of the Anti-VEGF G-rich V7t1 Aptamer by Covalent Dimeric Constructs
por: Riccardi, Claudia, et al.
Publicado: (2020)

Therapeutic potential of systemic brain rejuvenation strategies for neurodegenerative disease
por: Horowitz, Alana M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q6fsc9guppfd3eghn0itppf6ob